GlassScriptPhysician profile
Christopher Hoban
NPI 1992006753
$3,026.73
in general payments reported to CMS, 2019-2025
12 companies · $15.67 in 2025
The $15.67 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,548 · 2022: $127 · 2023: $67.26 · 2024: $269 · 2025: $15.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $351.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,519.18 | 2021 | |
| Depuy Synthes Sales INC. | $109.73 | 2024 | Na, Monovisc |
| Zimmer Biomet Holdings, INC. | $88.70 | 2022-2024 | Mymobility Platform |
| Bioventus LLC | $80.63 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Think Surgical, INC. | $45.69 | 2024 | |
| Smith+Nephew, INC. | $38.76 | 2023-2024 | Redapt, Real Intelligence |
| Davol INC. | $38.47 | 2022 | |
| Becton, Dickinson and Company | $36.97 | 2022 | |
| Ethicon US, LLC | $21.64 | 2023 | Stratafix, Ethicon, Vistaseal |
| Heron Therapeutics, INC. | $18.03 | 2022 | |
| Next Science LLC | $14.48 | 2021 | |
| Endo Pharmaceuticals INC. | $14.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hoban listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.